Clinical trial reportAmerican journal of hematologyPublished
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study
12 of 38 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- American journal of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Lymphoma, Non-Hodgkin; Sulfonamides; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Immunoconjugates; Myeloid Cell Leukemia Sequence 1 Protein; Rituximab; Bridged Bicyclo Compounds, Heterocyclic
- PubMed ID
- 36594167
- Open access
- Yes, open
- Added to directory
- Source checked